ASTERIVIR
Asterivir's team has been working for ten years at EPFL on the development of broad-spectrum antiviral drugs capable of being effective not only against existing viruses but also against emerging viruses. The technology has proven to be effective in vitro across a wide range of viruses and has also proven to be effective in vivo against Influenza, RSV, and HSV2. More recently, they found that their molecules developed against influenza have a good SARS-CoV-2 inhibitory response.
ASTERIVIR
Industry:
Biotechnology Health Care Hospital
Founded:
2019-01-01
Address:
Morges, Vaud, Switzerland
Country:
Switzerland
Status:
Active
Similar Organizations
Alliance for Artificial Intelligence in Healthcare
The AAIH is a coalition of technology developers, pharmaceutical company.
Context Therapeutics
Context Therapeutics is a clinical-stage biopharmaceutical company.
Akashi Therapeutics
Akashi Therapeutics is a clinical stage biopharmaceutical company.
Jenrin Discovery
Jenrin Discovery is a biopharmaceutical Company.
Current Employees Featured
More informations about "Asterivir"
Asterivir
Infections 100 years ago, Asterivir has the potential to do the same for the treatment of viral infections today. Technology. Asterivir technology can work against a wide range of viruses, even if they don’t exist today. A decade in the making. Long before COVID-19 emerged, a group of …See details»
Asterivir - Crunchbase Company Profile & Funding
Asterivir's team has been working for ten years at EPFL on the development of broad-spectrum antiviral drugs capable of being effective not only against …See details»
Asterivir 2025 Company Profile: Valuation, Funding & Investors
Asterivir General Information Description. Developer of a biotechnology platform designed to combat various viral diseases. The company offers a platform technology which has the …See details»
Asterivir - EuroQuity
Asterivir's team has been working for ten years at EPFL on the development of broad-spectrum antiviral drugs capable of being effective not only against existinSee details»
Asterivir - VentureRadar
Asterivir is a start-up biotech/pharmaceutical company developing broad-spectrum antiviral technology from École Polytechnique Fédérale de Lausanne (EPFL). Our virucidal molecules …See details»
Asterivir AG at the Swiss Biotech Day
Asterivir, a spin-off of the Swiss Federal Institute of Technology in Lausanne (EPFL), is developing a broad-spectrum antiviral platform with a unique mechanism of action. Asterivir’s medicines have shown efficacy in-vitro …See details»
Asterivir - Contacts, Employees, Board Members, Advisors & Alumni
Asterivir is a start-up biotech/pharmaceutical company. New. Resources. Advanced Search. Start Free Trial ... Experience the new Crunchbase, powered by AI . Experience the new …See details»
Dengue (Asterivir) - Drug Targets, Indications, Patents - Synapse
Dengue (Asterivir), Initially developed by Asterivir, Now, its global highest R&D status is Preclinical, Therapeutic Areas: Infectious Diseases, Active Indication: Dengue, Active Org.: …See details»
ASTERIVIR AG - VentureRadar
ASTERIVIR AG VentureRadar profile. Find out more about ASTERIVIR AG including the VentureRadar Innovation and Growth scores, Similar Companies and more.See details»
Asterivir AG - startup.ch
Asterivir AG: We are developing a broad spectrum antiviral platform that promises to produce medicines against a wide variety of viral diseases. We are pursuing influenza as our lead indication, but also have in vitro proof of concept data …See details»
Asterivir - Drug pipelines, Patents, Clinical trials - Synapse
Explore Asterivir with its drug pipeline, therapeutic area, technology platform, , Disease Domain:Infectious Diseases, Technology Platform:Unknown, Biological ...See details»
Asterivir - Switzerland Innovation Park Basel Area
Asterivir is a spin-out from the EPFL lab of Prof. Francesco Stellacci, licensing patents on broad-spectrum antivirals invented well before the emergence of SARS-CoV-2. Molecules employ a …See details»
Asterivir SA Company Profile - Dun & Bradstreet
Find company research, competitor information, contact details & financial data for Asterivir SA of Morges, WAADT. Get the latest business insights from Dun & Bradstreet.See details»
HSV-2(Asterivir) - Drug Targets, Indications, Patents - Synapse
HSV-2(Asterivir), Initially developed by Asterivir, Now, its global highest R&D status is Preclinical, Therapeutic Areas: Infectious Diseases, Active Indication: Herpesviridae Infections, Active …See details»
3C Bio - VentureRadar
Asterivir Switzerland Privately Held Asterivir is a start-up biotech/pharmaceutical company developing broad-spectrum antiviral technology from École Polytechnique Fédérale de …See details»
Asterivir SA - Swiss Biotech
Innovalex is a Switzerland-based company specializing in legal solutions for innovative businesses in the life sciences sector. It offers services ranging from business formation to …See details»
Asterivir - Sip Baselarea
Asterivir is a spin-out from the EPFL lab of Prof. Francesco Stellacci, licensing patents on broad-spectrum antivirals invented well before the emergence of SARS-CoV-2. Molecules employ a …See details»
Zika(Asterivir) - Drug Targets, Indications, Patents - Synapse
Zika(Asterivir), Initially developed by Asterivir, Now, its global highest R&D status is Preclinical, Therapeutic Areas: Infectious Diseases,Other Diseases, Active Indication: Zika Virus Infection, …See details»
Hepatitis-C(Asterivir) - Drug Targets, Indications, Patents - Synapse
Hepatitis-C(Asterivir), Initially developed by Asterivir, Now, its global highest R&D status is Preclinical, Therapeutic Areas: Infectious Diseases,Digestive System Disorders, Active …See details»
RSV(Asterivir) - Drug Targets, Indications, Patents - Synapse
RSV(Asterivir), Initially developed by Asterivir, Now, its global highest R&D status is Preclinical, Therapeutic Areas: Infectious Diseases, Active Indication: Respiratory Syncytial Virus …See details»